Changing leadership will rapidly advance company’s focus on LifeSphere® cognitive computing platform Miami, Florida, 13…
Learn MoreThe presentation explores productivity gains from automation in other settings to identify applicability for Regulatory professionals. Looking at Regulatory Information…
Learn MoreTHE CLIENT NEED A full-service contract research organization headquartered in Dallas, Texas, Total Clinical Trial Management (TCTM), was eager to…
Learn MoreThis webinar details how organizations can counter these challenges and become more sophisticated in their drug-related adverse event reporting by adopting state-of-the-art cognitive computing processes into their existing pharmacovigilance management systems. It addresses how cognitive computing technologies can automate a multitude of tasks in pharmacovigilance.
Learn MoreLifeSphere Safety MultiVigilance is the first pharmacovigilance solution (version 7.4.1.1-HF1) to have successfully completed E2B R3 testing with the XCOMP EudraVigilance system. Organizations using this same tested version should contact the European Medicines Agency and confirm that step 5b can be performed by themselves without the need for confirmation by the Agency.
Learn MoreArisGlobal today announced that a top-five global life sciences company based in the U.S. selected ArisGlobal’s LifeSphere Safety cloud solution suite as its enterprise-level pharmacovigilance and drug safety software platform to enhance their capabilities to deliver health and wellness outcomes to waiting patients around the globe and across all business units: pharmaceutical, medical devices and consumer packaged goods.
Learn MoreCHICAGO, IL. APRIL 7, 2017–ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, has announced…
Learn MoreLife sciences companies confront increasingly stringent requirements on safety signal detection and risk management. Regulatory authorities are taking steps to further safeguard patients by requiring companies to take more comprehensive steps to assess and monitor the benefit-risk balance of their products.
Learn MoreEMA SPOR Working group release the details to the SPOR Change Liaison Group for bringing Industry on-board the Organisational…
Learn MoreOur first blog on this topic addressed “The importance of mobility and medical affairs (MA) and its value to the organization is most definitely on the rise.” In this concluding blog we share specific examples of how mobile technology improves MA and arms you with the criteria and questions to ask as you investigate possible medical information solutions.
Learn More